Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07074912 · ClinicalTrials.gov registry record · NA
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
A NA study of Fever, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 440
- Enrollment target
- 1
- Study location
NCT07074912: Recruiting NA study of Fever, sponsored by University of Texas at Austin.
NCT07074912 is a NA study of Fever that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 440 participants, below the 575-participant average among 18 other Fever trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07074912, a NA study of Fever, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.
Primary Outcome
The primary outcome will be unscheduled revisits to the emergency department or urgent care (binary endpoint, i.e., yes/no). This information will be obtained directly from the caregiver/parent of the child. One week (7 days) after the initial visit to the emergency department, research personnel will call the parent/caregiver to ask about length of symptoms and any unscheduled return visits to the emergency department or urgent care for the same symptoms. Any return visits to an emergency depar
Conditions Studied
Interventions
- OTHER Prescription for weight-based dosing of antipyretic
- OTHER Standard discharge instructions
Study Locations (1)
Texas
- Dell Children's Medical Center - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2024-12-15 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
What NCT07074912 shows while recruiting
NCT07074912 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 575-participant average among 18 other Fever trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 2 interventions - of which Prescription for weight-based dosing of antipyretic is the first listed.
NCT07074912 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07074912 about?
NCT07074912 is a clinical study titled "Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department". The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.
What is the current status of trial NCT07074912?
This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2024-12-15. Estimated completion is 2026-03-15.
What conditions does trial NCT07074912 study?
This clinical trial studies the following conditions: Fever.
What interventions are being tested in trial NCT07074912?
The interventions under investigation include: Prescription for weight-based dosing of antipyretic (OTHER), Standard discharge instructions (OTHER).
Who is sponsoring clinical trial NCT07074912?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07074912 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fever
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07074912's enrollment target sits among peer trials
440 6th of 18 higher than 13 of 18 other Fever trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fever trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Remote Temperature Monitoring of Patients At Risk for Developing Fever
RECRUITING · NA
-
Study of an App to Facilitate Communication With Parents of Febrile Infants
COMPLETED · NA
-
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
RECRUITING
-
Safety of RSV Preventive Monoclonal Antibody
RECRUITING · Phase 4
-
Tympanic Thermometer Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI